Ideagen PLC (LON:IDEA)‘s stock had its “corporate” rating reiterated by equities research analysts at FinnCap in a research report issued on Monday. They presently have a GBX 69 ($0.86) target price on the stock. FinnCap’s price target would indicate a potential upside of 26.61% from the stock’s previous close.

Ideagen PLC (LON:IDEA) opened at 54.40 on Monday. The stock has a 50 day moving average of GBX 53.99 and a 200 day moving average of GBX 54.38. Ideagen PLC has a 52 week low of GBX 44.11 and a 52 week high of GBX 60.00. The company’s market cap is GBX 97.36 million.

In related news, insider Graeme Spenceley sold 250,000 shares of the firm’s stock in a transaction dated Tuesday, October 11th. The shares were sold at an average price of GBX 53 ($0.66), for a total value of £132,500 ($165,542.23).

About Ideagen PLC

Ideagen plc is a provider of enterprise governance, risk, and compliance (eGRC) and healthcare information management software for organizations operating within regulated industries. The Company offers GRC solutions, which offers products, such as Pentana, Q-Pulse, Quality Workbench, Proquis Enterprise, KnowledgeWorker and Ideagen Capture.

Receive News & Stock Ratings for Ideagen PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ideagen PLC and related stocks with our FREE daily email newsletter.